|
セキグチ ハルキ
SEKIGUCHI Haruki
関口 治樹 所属 医学部 医学科（東京女子医科大学病院） 職種 准教授 |
|
| 言語種別 | 英語 |
| 発表タイトル | Differences in the usefulness of aggressive lipid-lowering therapy among single-vessel and multi-vessel coronary artery disease patients: HIJ-PROPER sub-study |
| 会議名 | ESC Congress 2019 |
| 主催者 | European Society of Cardiology |
| 学会区分 | 国際学会及び海外の学会 |
| 発表形式 | ポスター掲示 |
| 講演区分 | 一般 |
| 発表者・共同発表者 | OGISO Masataka, ◎NOMURA Hidekimi, NAKAZAWA Mayui, WATANABE Erisa, SEKIGUCHI Haruki, ARASHI Hiroyuki, YAMAGUCHI Junichi, OGAWA Hiroshi, HAGIWARA Nobuhisa, |
| 発表年月日 | 2019/08/31 |
| 開催地 （都市, 国名） |
Paris, FRANCE |
| 概要 | Poster Session 1: Acute coronary syndromes, coronary artery disease: treatment
Topic : European Society Of Cardiology Session Type : Poster Session Conclusion: This study showed that ACS patients with SVD enjoyed significantly greater benefits from pitavastatin + ezetimibe therapy compared with pitavastatin monotherapy, whereas the patients with MVD did not. High rate of revascularization in acute phase of ACS might affect the efficacy of aggressive lipidlowering therapy and our results in the present study suggest different treatment approach would be necessary in ACS patients with MVD in modern early invasive strategy era. |